Report on the 3rd International Conference on Vaccines Research
The 3rd International Conference on Vaccines Research and Development (Vaccines R&D 2017) at the Sheraton Reston Hotel, Reston located within the Washington, D.C. metropolitan area, brought together more than 250 experts of the leading institutes and organizations to share their knowledge and research findings in the development of vaccines.
United Scientific Group (USG) is obliged to the lead sponsors and exhibitor for the Vaccines R&D-2017 are Mucosis, Sanofi Pasteur, Desert King International and GenScript respectively for their outstanding support and participation.
Vaccines R&D-2017 started with the inaugural ceremony dais shared with Sr. Vice President of United Scientific Group; and Mahin Khatami, National Cancer Institute (retired), USA
Day-1 keynote session starred with Jay A. Berzofsky, Center for Cancer Research, National Cancer Institute, USA; Roy Curtiss, III, Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, USA; Peter L. Nara, Biological Mimetics, Inc., USA; Stephen L. Hoffman, Sanaria Inc., USA; Michael G. Hanna, Vaccinogen Inc., USA and Scott M. White, Inovio Pharmaceuticals, Inc., USA.
The post lunch session continued with special talks and a special session on “Vaccine Regulation” and continued with poster presentations by attendees from all around the world.
The second day of the conference started with three parallel sessions Track-A: “Symposium Title: The Long Road to an HIV Vaccine” Track-B: Cancer Vaccines & Veterinary Vaccines and Track-C: Infectious & Non-Infectious Diseases and Biodefense Vaccines.
Day three of the summit continues with Track-A: “Symposium Title: The Long Road to an HIV Vaccine” and Track-D & E and it was long program and busy schedule. Overall, the meeting was well received and attended, promoting a lively interaction among the attendees and fostering several potential interactions.
